Free Newsletter
Obama, McCain united against drug costs
Despite a lack of socialized medicine in the United States, the U.S. government pays a hefty 45 percent of the total expenditure of healthcare, and drugs represent a large percentage of the costs. Both Obama and McCain are prioritizing big pharma in their campaign goals to cut costs, which might be part of the reason for industry stock drops. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: